Method of conferring a protective immune response to norovirus
AssigneeTakeda Vaccines, Inc.
InventorsCharles RICHARDSON, Thomas S. VEDVICK, Thomas R. FOUBERT, William TINO
Life of this patent
Estimating the term…
Abstract
The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.
Claims22
-27. (canceled)
A method of eliciting protective immunity to a Norovirus infection in a human comprising administering to the human a vaccine comprising at least two Norovirus virus-like particles (VLPs), wherein the at least two VLPs represent different Norovirus genotypes, and wherein the vaccine is able to elicit immunity against at least one Norovirus genotype that does not belong to genogroup I.
Dependencies are inferred from the claim text.